EphA2 expression levels significantly correlated with clinical stage of colon adenocarcinoma and testicular germ cell tumors, where EphA2 levels increased in advanced clinical stages, while in kidney renal cell carcinoma and ovarian carcinoma, EphA2 expression decreased. The gene discussed is EPHA2; the disease is ovarian carcinoma.